Cardiac Troponins: Contemporary Biological Data and New Methods of Determination

References

• Ohtsuki I, Morimoto S. Troponin: regulatory function and disorders. Biochem Biophys Res Commun. 2008;369(1):62–73. doi:10.1016/j.bbrc.2007.11.187
   PubMed Web of Science ®Google Scholar
• Ohtsuki I. Troponin: structure, function and dysfunction. Adv Exp Med Biol. 2007;592:21–36. doi:10.1007/978-4-431-38453-3_4
   PubMed Web of Science ®Google Scholar
• Mogensen J. Troponin mutations in cardiomyopathies. Adv Exp Med Biol. 2007;592:201–226. doi:10.1007/978-4-431-38453-3_18
   PubMed Web of Science ®Google Scholar
• Luo J, Zhao W, Gan Y, et al. Cardiac troponin I R193H mutation is associated with mitochondrial damage in cardiomyocytes. DNA Cell Biol. 2021;40(2):184–191. doi:10.1089/dna.2020.5828
   PubMed Web of Science ®Google Scholar
• Pasquale F, Syrris P, Kaski JP, et al. Long-term outcomes in hypertrophic cardiomyopathy caused by mutations in the cardiac troponin T gene. Circ Cardiovasc Genet. 2012;5(1):10–17. doi:10.1161/CIRCGENETICS.111.959973
   PubMedGoogle Scholar
• Tobacman LS, Cammarato A. Cardiomyopathic troponin mutations predominantly occur at its interface with actin and tropomyosin. J Gen Physiol. 2021;153(3):e202012815. doi:10.1085/jgp.202012815
   PubMed Web of Science ®Google Scholar
• Morimoto S. Molecular pathogenic mechanisms of cardiomyopathies caused by mutations in cardiac troponin T. Adv Exp Med Biol. 2007;592:227–239. doi:10.1007/978-4-431-38453-3_19
   PubMed Web of Science ®Google Scholar
• Duplyakov DV, Chaulin AM. Mutations of heart troponines, associated with cardiomyopathies. Kardiologiya: Novosti, Mneniya, Obuchenie [Cardiology: News, Opinions, Training]. 2019;7(3):8–17. In Russian. doi:10.24411/2309-1908-2019-13001
   Google Scholar
• Katruha IA. Troponin complex of the human heart. Structure and functions. Adv Biol Chem. 2013;53:149–194. In Russian.
   Google Scholar
• Chaulin AM, Duplyakov DV. Biomarkers of acute myocardial infarction: diagnostic and prognostic value. Part 1. J Clin Pract. 2020;11(4):75–84. In Russian. doi:10.17816/clinpract48893
   Google Scholar
• Ricchiuti V, Apple FS. RNA expression of cardiac troponin T isoforms in diseased human skeletal muscle. Clin Chem. 1999;45(12):2129–2135. doi:10.1093/clinchem/45.12.2129
   PubMed Web of Science ®Google Scholar
• McLaurin MD, Apple FS, Voss EM, et al. Cardiac troponin I, cardiac troponin T, and creatine kinase MB in dialysis patients without ischemic heart disease: evidence of cardiac troponin T expression in skeletal muscle. Clin Chem. 1997;43(6):976–982. doi:10.1093/clinchem/43.6.976
   PubMed Web of Science ®Google Scholar
• Ricchiuti V, Voss EM, Ney A, et al. Cardiac troponin T isoforms expressed in renal diseased skeletal muscle will not cause false-positive results by the second generation cardiac troponin T assay by Boehringer Mannheim. Clin Chem. 1998;44(9):1919–1924. doi:10.1093/clinchem/44.9.1919
   PubMed Web of Science ®Google Scholar
• Messner B, Baum H, Fischer P, et al. Expression of messenger RNA of the cardiac isoforms of troponin T and I in myopathic skeletal muscle. Am J Clin Pathol. 2000;114(4):544–549. doi:10.1309/8KCL-UQRF-6EEL-36XK
   PubMed Web of Science ®Google Scholar
• Wens SCA, Schaaf GJ, Michels M, et al. Elevated plasma cardiac troponin T levels caused by skeletal muscle damage in Pompe disease. Circ Cardiovasc Genet. 2016;9(1):6–13. doi:10.1161/CIRCGENETICS.115.001322
   PubMed Web of Science ®Google Scholar
• Apple FS. Tissue specificity of cardiac troponin I, cardiac troponin T and creatine kinase-MB. Clin Chim Acta. 1999;284(2):151–159. doi:10.1016/s0009-8981(99)00077-7
   PubMed Web of Science ®Google Scholar
• Rusakov DY, Vologdina NN, Tulayeva ON. The development of striated cardiac muscle tissue in the walls of the caval and pulmonary veins. J Anatomy Histopathol. 2015;4(3):105. In Russian. doi:10.18499/2225-7357-2015-4-3-105-105
   Google Scholar
• Cavalcanti JS, Santos LP. Morphofunctional study of the junction between the left atrium and the pulmonary veins in patient with pulmonary hypertension. Arq Bras Cardiol. 2001;77(3):229–234. English, Portuguese. doi:10.1590/s0066-782x2001000900003
   PubMedGoogle Scholar
• Hammerer-Lercher A, Erlacher P, Bittner R, et al. Clinical and experimental results on cardiac troponin expression in Duchenne muscular dystrophy. Clin Chem. 2001;47(3):451–458. doi:10.1093/clinchem/47.3.451
   PubMed Web of Science ®Google Scholar
• Schmid J, Liesinger L, Birner-Gruenberger R, et al. Elevated cardiac troponin T in patients with skeletal myopathies. J Am Coll Cardiol. 2018;71(14):1540–1549. doi:10.1016/j.jacc.2018.01.070
   PubMed Web of Science ®Google Scholar
• Dhoot GK, Gell PG, Perry SV. The localization of the different forms of troponin I in skeletal and cardiac muscle cells. Exp Cell Res. 1978;117(2):357–370. doi:10.1016/0014-4827(78)90149-0
   PubMed Web of Science ®Google Scholar
• Dhoot GK, Perry SV. Distribution of polymorphic forms of troponin components and tropomyosin in skeletal muscle. Nature. 1979;278(5706):714–718. doi:10.1038/278714a0
   PubMed Web of Science ®Google Scholar
• Filatov VL, Katruha AG, Bulargina TV, et al. Troponin: structure, properties and mechanism of functioning. Biochemistry. 1999;64(9):1155–1174. In Russian.
   Web of Science ®Google Scholar
• Chaulin AM, Karslyan LS, Bazyuk EV, et al. [Clinical and diagnostic value of cardiac markers in human biological fluids]. Kardiologiia. 2019;59(11):66–75. In Russian. doi:10.18087/cardio.2019.11.n414
   PubMed Web of Science ®Google Scholar
• Velkov VV, Opredelentseva SV, Shvidenko IG, Norkin IA, Korshunov GV, Gladkova EV. The new international criteria of cardiac infarction and highly sensitive troponins: new possibilities and new problems. Klin Lab Diagn. 2014;59(8):43–53. In Russian.
   PubMedGoogle Scholar
• Feng J, Schaus BJ, Fallavollita JA, et al. Preload induces troponin I degradation independently of myocardial ischemia. Circulation. 2001;103(16):2035–2037. doi:10.1161/01.cir.103.16.2035
   PubMed Web of Science ®Google Scholar
• Chaulin AM, Duplyakov DV. Increased cardiac troponins, not associated with acute coronary syndrome. Part 1. Kardiologiya: Novosti, Mneniya, Obuchenie [Cardiology: News, Opinions, Training]. 2019;7(2):13–23. In Russian. doi:10.24411/2309-1908-2019-12002
   Google Scholar
• Chaulin AM, Duplyakov DV. Increased cardiac troponins, not associated with acute coronary syndrome. Part 2. Kardiologiya: Novosti, Mneniya, Obuchenie [Cardiology: News, Opinions, Training]. 2019;7(2):24–35. In Russian. doi:10.24411/2309-1908-2019-12003
   Google Scholar
• Vafaie M. State-of-the-art diagnosis of myocardial infarction. Diagnosis (Berl). 2016;3(4):137–142. doi:10.1515/dx-2016-0024
   PubMedGoogle Scholar
• Thygesen K, Alpert JS, Jaffe AS, et al.; Executive Group on behalf of the Joint European Society of Cardiology (ESC)/American College of Cardiology (ACC)/American Heart Association (AHA)/World Heart Federation (WHF) Task Force for the Universal Definition of Myocardial Infarction. Fourth universal definition of myocardial infarction (2018). Glob Heart. 2018;13(4):305–338. doi:10.1016/j.gheart.2018.08.004.
   PubMed Web of Science ®Google Scholar
• Chaulin AM, Duplyakov DV. Biomarkers of acute myocardial infarction: diagnostic and prognostic value. Part 2 (literature review). J Clin Pract. 2020;11(4):70–82. doi:10.17816/clinpract48893
   Google Scholar
• Kelley WE, Januzzi JL, Christenson RH. Increases of cardiac troponin in conditions other than acute coronary syndrome and heart failure. Clin Chem. 2009;55(12):2098–2112. doi:10.1373/clinchem.2009.130799
   PubMed Web of Science ®Google Scholar
• Chaulin AM, Karslyan LS, Duplyakov DV. Non-coronarogenic causes of increased cardiac troponins in clinical practice. J Clin Pract. 2019;10(4):81–93. In Russian. doi:10.17816/clinpract16309
   Google Scholar
• Chaulin AM, Svechkov NA, Volkova SL, Grigoreva YV. Diagnostic value of cardiac troponins in elderly patients without myocardial infarction. Mod Prob Sci Educ. 2020;6. doi:10.17513/spno.30302.
   Google Scholar
• Long B, Long DA, Tannenbaum L, Koyfman A. An emergency medicine approach to troponin elevation due to causes other than occlusion myocardial infarction. Am J Emerg Med. 2020;38(5):998–1006. doi:10.1016/j.ajem.2019.12.007
   PubMed Web of Science ®Google Scholar
• Chaulin AM, Duplyakov DV. On the potential effect of circadian rhythms of cardiac troponins on the diagnosis of acute myocardial infarction. Signa Vitae. 2021. doi:10.22514/sv.2021.050
   Web of Science ®Google Scholar
• Xue F, Jiang TB, Jiang B, et al. Cardiac troponin I elevation with supraventricular tachycardia: two case reports and review of the literature. BMC Res Notes. 2014;7:136. doi:10.1186/1756-0500-7-136
   PubMedGoogle Scholar
• Manjunath L, Yeluru A, Rodriguez F. 27-year-old man with a positive troponin: a case report. Cardiol Ther. 2018;7(2):197–204. doi:10.1007/s40119-018-0120-3
   PubMed Web of Science ®Google Scholar
• Lum G, Solarz DE, Farney L. False positive cardiac troponin results in patients without acute myocardial infarction. Lab Med. 2006;37(9):546–550. doi:10.1309/T94UUXTJ3TX5Y9W2
   Google Scholar
• Marinheiro R, Amador P, Parreira L, et al. False positive troponin I rendering two admissions for “recurrent acute myopericarditis”. Open Cardiovasc Med J. 2018;12:55–58. doi:10.2174/1874192401812010055
   PubMed Web of Science ®Google Scholar
• Richardson AJ, Leckie T, Watkins ER, et al. Post marathon cardiac troponin T is associated with relative exercise intensity. J Sci Med Sport. 2018;21(9):880–884. doi:10.1016/j.jsams.2018.02.005
   PubMed Web of Science ®Google Scholar
• Lazzarino AI, Hamer M, Gaze D, et al. The association between cortisol response to mental stress and high sensitivity cardiac troponin T plasma concentration in healthy adults. J Am Coll Cardiol. 2013;62(18):1694–1701. doi:10.1016/j.jacc.2013.05.070
   PubMed Web of Science ®Google Scholar
• Lauer B, Niederau C, Kuhl U, et al. Cardiac troponin T in patients with clinically suspected myocarditis. J Am Coll Cardiol. 1997;30(5):1354–1359. doi:10.1016/S0735-1097(97)00317-3
   PubMed Web of Science ®Google Scholar
• Ukena C, Kindermann M, Mahfoud F, et al. Diagnostic and prognostic validity of different biomarkers in patients with suspected myocarditis. Clin Res Cardiol. 2014;103(9):743–751. doi:10.1007/s00392-014-0709-z
   PubMed Web of Science ®Google Scholar
• Kumar A, Kumar A, Paladugu B, et al. Transforming growth factor-beta 1 blocks in vitro cardiac myocyte depression induced by tumour necrosis factor-alpha, interleukin-1 beta, and human septic shock serum. Crit Care Med. 2007;35(2):358–364. doi:10.1097/01.CCM.0000254341.87098.A4
   PubMed Web of Science ®Google Scholar
• Bessiere F, Khenifer S, Dubourg J, et al. Prognostic value of troponins in sepsis: a meta-analysis. Intensive Care Med. 2013;39(7):1181–1189. doi:10.1007/s00134-013-2902-3
   PubMed Web of Science ®Google Scholar
• Rosjo H, Varpula M, Hagve TA, et al. Circulating high-sensitive troponin T in severe sepsis and septic shock: distribution, associated factors, and relation to outcome. Intensive Care Med. 2011;37(1):77–85. doi:10.1007/s00134-010-2051-x
   PubMed Web of Science ®Google Scholar
• Dubin RF, Li Y, He J, et al. Predictors of high sensitivity cardiac troponin T in chronic kidney disease patients: a cross-sectional study in the chronic renal insufficiency cohort (CRIC). BMC Nephrol. 2013;14:229. doi:10.1186/1471-2369-14-229
   PubMed Web of Science ®Google Scholar
• Zumrutdal AO, Bakinen O, Ucan H, et al. Relationship between uremic myopathy and false-positive cardiac troponin T test. Nephron. 2000;86:522–523. doi:10.1159/000045852
   PubMed Web of Science ®Google Scholar
• Chesnaye NC, Szummer K, Bárány P, et al.; EQUAL Study Investigators †; EQUAL Study Investigators†. Association between renal function and troponin T over time in stable chronic kidney disease patients. J Am Heart Assoc. 2019;8(21):e013091. doi:10.1161/JAHA.119.013091
   PubMed Web of Science ®Google Scholar
• Bukkapatnam RN, Robinson M, Turnipseed S, et al. Relationship of myocardial ischemia and injury to coronary artery disease in patients with supraventricular tachycardia. Am J Cardiol. 2010;106(3):374–377. doi:10.1016/j.amjcard.2010.03.035
   PubMed Web of Science ®Google Scholar
• Zellweger MJ, Schaer BA, Cron TA, et al. Elevated troponin levels in absence of coronary artery disease after supraventricular tachycardia. Swiss Med Wkly. 2003;133(31–32):439–441.
   PubMed Web of Science ®Google Scholar
• Chaulin AM, Duplyakov DV. MicroRNAs in atrial fibrillation: pathophysiological aspects and potential biomarkers. Int J Biomed. 2020;10(3):198–205. doi:10.21103/Article10(3)_RA3
   Web of Science ®Google Scholar
• Chaulin AM, Abashina OE, Duplyakov DV. Pathophysiological mechanisms of cardiotoxicity in chemotherapeutic agents. Russ Open Med J. 2020;9:e0305. doi:10.15275/rusomj.2020.0305
   Web of Science ®Google Scholar
• Wilhelm J, Hettwer S, Schuermann M, et al. Elevated troponin in septic patients in the emergency department: frequency, causes, and prognostic implications. Clin Res Card. 2014;103(7):561–567. doi:10.1007/s00392-014-0684-4
   PubMed Web of Science ®Google Scholar
• Maekawa A, Lee JK, Nagaya T, et al. Overexpression of calpastatin by gene transfer prevents troponin I degradation and ameliorates contractile dysfunction in rat hearts subjected to ischemia/reperfusion. J Mol Cell Cardiol. 2003;35(10):1277–1284. doi:10.1016/s0022-2828(03)00238-4
   PubMed Web of Science ®Google Scholar
• O’Hanlon R, Wilson M, Wage R, et al. Troponin release following endurance exercise: is inflammation the cause? A cardiovascular magnetic resonance study. J Cardiovasc Magn Reson. 2010;12(1):38. doi:10.1186/1532-429X-12-38
   PubMed Web of Science ®Google Scholar
• Chaulin AM, Karslyan LS, Grigorieva EV, et al. Metabolism of cardiac troponins (literature review). Complex Issues Cardiovasc Dis. 2019;8(4):103–115. In Russian. doi:10.17802/2306-1278-2019-8-4-103-115
   Google Scholar
• Garcia-Osuna A, Gaze D, Grau-Agramunt M, et al. Ultrasensitive quantification of cardiac troponin I by a single molecule counting method: analytical validation and biological features. Clin Chim Acta. 2018;486:224‐231. doi:10.1016/j.cca.2018.08.015
   PubMed Web of Science ®Google Scholar
• Apple FS. The specificity of biochemical markers of cardiac damage: a problem solved. Clin Chem Lab Med. 1999;37(11–12):1085–1089. doi:10.1515/CCLM.1999.158
   PubMed Web of Science ®Google Scholar
• Chaulin AM, Duplyakova PD, Duplyakov DV. Circadian rhythms of cardiac troponins: mechanisms and clinical significance. Russ J Cardiol. 2020;25(3):4061. doi:10.15829/1560-4071-2020-4061
   Google Scholar
• Shah A, Griffiths M, Lee KK, et al. High sensitivity cardiac troponin and the under-diagnosis of myocardial infarction in women. BMJ. 2015;350:g7873. doi:10.1136/bmj.g7873
   PubMed Web of Science ®Google Scholar
• Apple FS, Jaffe AS, Collinson P, et al. IFCC educational materials on selected analytical and clinical applications of high sensitivity cardiac troponin assays. Clin Biochem. 2015;48(4–5):201‐203. doi:10.1016/j.clinbiochem.2014.08.021
   Web of Science ®Google Scholar
• Cediel G, Codina P, Spitaleri G, et al. Gender-related differences in heart failure biomarkers. Front Cardiovasc Med. 2021;7:617705. doi:10.3389/fcvm.2020.617705
   PubMed Web of Science ®Google Scholar
• Gore MO, Seliger SL, deFilippi CR, et al. Age- and sex-dependent upper reference limits for the high-sensitivity cardiac troponin T assay. J Am Coll Cardiol. 2014;63:1441–1448. doi:10.1016/j.jacc.2013.12.032
   PubMed Web of Science ®Google Scholar
• Trupp RJ, Albert G, Ziegler A. Sex-specific 99th percentiles derived from the AACC universal sample bank for the roche gen 5 cTnT assay: comorbidities and statistical methods influence derivation of reference limits. Clin Biochem. 2018;52:173. doi:10.1016/j.clinbiochem.2017.11.003
   PubMed Web of Science ®Google Scholar
• Klinkenberg LJJ, Wildi K, van der Linden N, et al. Diurnal rhythm of cardiac troponin: consequences for the diagnosis of acute myocardial infarction. Clin Chem. 2016;62(12):1602–1611. doi:10.1373/clinchem.2016.257485
   PubMed Web of Science ®Google Scholar
• Aakre KM, Roraas T, Petersen PH, et al. Weekly and 90-minute biological variations in cardiac troponin T and cardiac troponin I in hemodialysis patients and healthy controls. Clin Chem. 2014;60(6):838‐847. doi:10.1373/clinchem.2013.216978
   PubMed Web of Science ®Google Scholar
• Chaulin AM, Duplyakov DV. High-sensitivity cardiac troponins: circadian rhythms. Cardiovasc Ther Prev. 2021;20(1):2639. In Russian. doi:10.15829/1728-8800-2021-2639
   Google Scholar
• van der Linden N, Cornelis T, Klinkenberg LJJ, et al. Strong diurnal rhythm of troponin T, but not troponin I, in a patient with renal dysfunction. Int J Cardiol. 2016;221:287–288. doi:10.1016/j.ijcard.2016.06.268
   PubMed Web of Science ®Google Scholar
• Roffi M, Patrono C, Collet J, et al. 2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: task force for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J. 2016;37:267–315. doi:10.1093/eurheartj/ehv320
   PubMed Web of Science ®Google Scholar
• Seneviratna A, Lim GH, Devi A, et al. Circadian dependence of infarct size and acute heart failure in ST elevation myocardial infarction. PLoS One. 2015;10(6):e0128526. doi:10.1371/journal.pone.0128526
   PubMed Web of Science ®Google Scholar
• Suárez-Barrientos A, López-Romero P, Vivas D, et al. Circadian variations of infarct size in acute myocardial infarction. Heart. 2011;97:970–976. doi:10.1136/hrt.2010.212621
   PubMed Web of Science ®Google Scholar
• Ziebig R, Lun A, Hocher B, et al. Renal elimination of troponin T and troponin I. Clin Chem. 2003;49(7):1191–1193. doi:10.1373/49.7.1191
   PubMed Web of Science ®Google Scholar
• Ellis K, Dreisbach AW, Lertora J. Plasma elimination of cardiac troponin I in end-stage renal disease. South Med J. 2001;94(10):993–996. doi:10.1097/00007611-200194100-00011
   PubMed Web of Science ®Google Scholar
• Pervan P, Svaguša T, Prkačin I, et al. Urine high sensitive Troponin I measuring in patients with hypertension. Signa Vitae. 2017;13(Suppl3):62–64. doi:10.22514/SV133.062017.13
   Google Scholar
• Chaulin AM, Duplyakova PD, Bikbaeva GR, et al. Concentration of high-sensitivity cardiac troponin I in the oral fluid in patients with acute myocardial infarction: a pilot study. Russ J Cardiol. 2020;25(12):3814. doi:10.15829/1560-4071-2020-3814
   Google Scholar
• Mirzaii-Dizgah I, Riahi E. Salivary high-sensitivity cardiac troponin T levels in patients with acute myocardial infarction. Oral Dis. 2013;19(2):180–184. doi:10.1111/j.1601-0825.2012.01968.x
   PubMed Web of Science ®Google Scholar
• Chaulin AM, Duplyakov DV. Increased natriuretic peptides not associated with heart failure. Russ J Cardiol. 2020;25:4140. doi:10.15829/1560-4071-2020-4140
   Google Scholar
• Potkonjak AM, Sabolović Rudman S, Nikolac Gabaj N, et al. Urinary troponin concentration as a marker of cardiac damage in pregnancies complicated with preeclampsia. Med Hypotheses. 2020;144:110252. doi:10.1016/j.mehy.2020.110252
   PubMed Web of Science ®Google Scholar
• Nowakowski JF. Use of cardiac enzymes in the evaluation of acute chest pain. Ann Emerg Med. 1986;15(3):354–360. doi:10.1016/s0196-0644(86)80584-4
   PubMed Web of Science ®Google Scholar
• Alpert JS, Thygesen K, Antman E, et al. Myocardial infarction redefined–a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction [published correction appears in J Am Coll Cardiol 2001;37(3):973]. J Am Coll Cardiol. 2000;36(3):959‐969. doi:10.1016/s0735-1097(00)00804-4
   Web of Science ®Google Scholar
• Cummins B, Auckland ML, Cummins P. Cardiac-specific troponin-I radioimmunoassay in the diagnosis of acute myocardial infarction. Am Heart J. 1987;113(6):1333‐1344. doi:10.1016/0002-8703(87)90645-4
   PubMed Web of Science ®Google Scholar
• Venge P, Lindahl B. Cardiac troponin assay classification by both clinical and analytical performance characteristics: a study on outcome prediction. Clin Chem. 2013;59:976–981. doi:10.1373/clinchem.2012.194928
   PubMed Web of Science ®Google Scholar
• Katus HA, Looser S, Hallermayer K, et al. Development and in vitro characterization of a new immunoassay of cardiac troponin T. Clin Chem. 1992;38(3):386‐393. doi:10.1093/clinchem/38.3.386
   Web of Science ®Google Scholar
• Hermsen D, Apple F, Garcia-Beltràn L, et al. Results from a multicenter evaluation of the 4th generation Elecsys Troponin T assay. Clin Lab. 2007;53(1–2):1‐9.
   PubMed Web of Science ®Google Scholar
• Reichlin T, Hochholzer W, Stelzig C, et al. Incremental value of copeptin for rapid rule out of acute myocardial infarction. J Am Coll Cardiol. 2009;54(1):60‐68. doi:10.1016/j.jacc.2009.01.076
   PubMed Web of Science ®Google Scholar
• Mingels A, Jacobs L, Michielsen E, et al. Reference population and marathon runner sera assessed by highly sensitive cardiac troponin T and commercial cardiac troponin T and I assays. Clin Chem. 2009;55(1):101‐108. doi:10.1373/clinchem.2008.106427
   PubMed Web of Science ®Google Scholar
• Keller T, Zeller T, Ojeda F, et al. Serial changes in highly sensitive troponin I assay and early diagnosis of myocardial infarction. JAMA. 2011;306(24):2684‐2693. doi:10.1001/jama.2011.1896
   PubMed Web of Science ®Google Scholar
• Adams JE, Bodor GS, Dávila-Román VG, et al. Cardiac troponin I. A marker with high specificity for cardiac injury. Circulation. 1993;88(1):101‐106. doi:10.1161/01.cir.88.1.101
   Web of Science ®Google Scholar
• Apple FS. Counterpoint: standardization of cardiac troponin I assays will not occur in my lifetime. Clin Chem. 2012;58(1):169‐171. doi:10.1373/clinchem.2011.166165
   Web of Science ®Google Scholar
• Boeddinghaus J, Nestelberger T, Koechlin L, et al.; APACE Investigators. Early diagnosis of myocardial infarction with point-of-care high-sensitivity cardiac troponin I. J Am Coll Cardiol. 2020;75(10):1111–1124. doi:10.1016/j.jacc.2019.12.065
   PubMed Web of Science ®Google Scholar
• Anand A, Shah ASV, Beshiri A, et al. Global adoption of high-sensitivity cardiac troponins and the universal definition of myocardial infarction. Clin Chem. 2019;65(3):484‐489. doi:10.1373/clinchem.2018.298059
   Web of Science ®Google Scholar
• Zahran S, Figueiredo VP, Graham MM, Schulz R, Hwang PM. Proteolytic digestion of serum cardiac troponin I as marker of ischemic severity. JALM. 2018;3:450–455. doi:10.1373/jalm.2017.025254
   Google Scholar
• Katrukha IA, Kogan AE, Vylegzhanina AV, et al. Full-size cardiac troponin I and its proteolytic fragments in blood of patients with acute myocardial infarction: antibody selection for assay development. Clin Chem. 2018;64(7):1104–1112. doi:10.1373/clinchem.2017.286211
   PubMed Web of Science ®Google Scholar
• Katrukha IA, Kogan AE, Vylegzhanina AV, et al. Thrombin-mediated degradation of human cardiac troponin T. Clin Chem. 2017;63(6):1094–1100. doi:10.1373/clinchem.2016.266635
   PubMed Web of Science ®Google Scholar
• Chaulin AM, Karslyan LS, Nurbaltaeva DA, et al. Cardial troponins metabolism under normal and pathological conditions. Siber Med Rev. 2019;(6):5–14. doi:10.20333/2500136-2019-6-5-14
   Google Scholar
• Lippi G, Aloe R, Meschi T, et al. Interference from heterophilic antibodies in troponin testing. Case report and systematic review of the literature. Clin Chim Acta. 2013;426:79–84. doi:10.1016/j.cca.2013.09.004
   PubMed Web of Science ®Google Scholar
• Adamczyk M, Brashear RJ, Mattingly PG. Circulating cardiac troponin-I autoantibodies in human plasma and serum. Ann N Y Acad Sci. 2009;1173(1):67–74. doi:10.1111/j.1749-6632.2009.04617.x
   PubMedGoogle Scholar
• Tang G, Wu Y, Zhao W, Shen Q. Multiple immunoassay systems are negatively interfered by circulating cardiac troponin I autoantibodies. Clin Exp Med. 2012;12(1):47–53. doi:10.1007/s10238-011-0141-x
   PubMed Web of Science ®Google Scholar
• Armbruster DA, Pry T. Limit of blank, limit of detection and limit of quantitation. Clin Biochem Rev. 2008;29(Suppl1):S49‐S52.
   PubMedGoogle Scholar
• Apple FS. A new season for cardiac troponin assays: it’s time to keep a scorecard. Clin Chem. 2009;55:1303–1306. doi:10.1373/clinchem.2009.128363
   PubMed Web of Science ®Google Scholar
• Collinson PO, Heung YM, Gaze D, et al. Influence of population selection on the 99th percentile reference value for cardiac troponin assays. Clin Chem. 2012;58(1):219‐225. doi:10.1373/clinchem.2011.171082
   Web of Science ®Google Scholar
• Eggers KM, Apple FS, Lind L, et al. The applied statistical approach highly influences the 99th percentile of cardiac troponin I. Clin Biochem. 2016;49(15):1109‐1112. doi:10.1016/j.clinbiochem.2016.08.012
   PubMed Web of Science ®Google Scholar
• Cervellin G, Mattiuzzi C, Bovo C, et al. Diagnostic algorithms for acute coronary syndrome-is one better than another? Ann Transl Med. 2016;4(10):193. doi:10.21037/atm.2016.05.16
   PubMed Web of Science ®Google Scholar
• Sörensen NA, Neumann JT, Ojeda F, et al. Challenging the 99th percentile: a lower troponin cutoff leads to low mortality of chest pain patients. Int J Cardiol. 2017;232:289–293. doi:10.1016/j.ijcard.2016.12.167
   PubMed Web of Science ®Google Scholar
• Lippi G, Bonfanti L, Dipalo M, et al. Clinical, organizational and economic analysis of high-sensitivity cardiac troponin testing in the emergency department. Ann Res Hosp. 2017;1:44. doi:10.21037/arh.2017.09.02
   Google Scholar
• Pickering JW, Than MP, Cullen L, et al. Rapid rule-out of acute myocardial infarction with a single high-sensitivity cardiac troponin T measurement below the limit of detection: a collaborative meta-analysis [published correction appears in Ann Intern Med. 2017 Oct 3;167(7):528]. Ann Intern Med. 2017;166(10):715‐724. doi:10.7326/M16-2562
   PubMed Web of Science ®Google Scholar
• Ferencik M, Mayrhofer T, Lu MT, et al. High-sensitivity cardiac troponin I as a gatekeeper for coronary computed tomography angiography and stress testing in patients with acute chest pain. Clin Chem. 2017;63:1724–1733. doi:10.1373/clinchem.2017.275552
   PubMed Web of Science ®Google Scholar
• Jaeger C, Wildi K, Twerenbold R, et al. One-hour rule-in and rule-out of acute myocardial infarction using high-sensitivity cardiac troponin I. Am Heart J. 2016;171(1):92‐102.e1025. doi:10.1016/j.ahj.2015.07.022
   PubMed Web of Science ®Google Scholar
• Available from: https://www.ifcc.org/media/478231/high-sensitivity-cardiac-troponin-i-and-t-assay-analytical-characteristics-designated-by-manufacturer-v122019.pdf. Accessed March 25, 2020.
   Google Scholar
• Reichlin T, Schindler C, Drexler B, et al. One-hour rule-out and rule-in of acute myocardial infarction using high-sensitivity cardiac troponin T. Arch Intern Med. 2012;172(16):1211–1218. doi:10.1001/archinternmed.2012.3698
   PubMedGoogle Scholar
• Twerenbold R, Neumann JT, Sörensen NA, et al. Prospective Validation of the 0/1-h Algorithm for Early Diagnosis of Myocardial Infarction. J Am Coll Cardiol. 2018;72(6):620–632. doi:10.1016/j.jacc.2018.05.040
   PubMed Web of Science ®Google Scholar
• Twerenbold R, Costabel JP, Nestelberger T, et al. Outcome of applying the ESC 0/1-hour algorithm in patients with suspected myocardial infarction. J Am Coll Cardiol. 2019;74(4):483–494. doi:10.1016/j.jacc.2019.05.046
   PubMed Web of Science ®Google Scholar
• Shah ASV, Anand A, Strachan FE, et al. High-sensitivity troponin in the evaluation of patients with suspected acute coronary syndrome: a stepped-wedge, cluster-randomised controlled trial. Lancet. 2018;392(10151):919–928. doi:10.1016/S0140-6736(18)31923-8
   PubMed Web of Science ®Google Scholar
• Shah AS, Anand A, Sandoval Y, et al. High-sensitivity cardiac troponin I at presentation in patients with suspected acute coronary syndrome: a cohort study. Lancet. 2015;386(10012):2481–2488. doi:10.1016/S0140-6736(15)00391-8
   PubMed Web of Science ®Google Scholar
• Boeddinghaus J, Reichlin T, Cullen L, et al. Two-hour algorithm for triage toward rule-out and rule-in of acute myocardial infarction by use of high-sensitivity cardiac troponin I. Clin Chem. 2016;62(3):494–504. doi:10.1373/clinchem.2015.249508
   PubMed Web of Science ®Google Scholar
• Nestelberger T, Wildi K, Boeddinghaus J, et al. Characterization of the observe zone of the ESC 2015 high-sensitivity cardiac troponin 0h/1h-algorithm for the early diagnosis of acute myocardial infarction. Int J Cardiol. 2016;207:238–245. doi:10.1016/j.ijcard.2016.01.112
   PubMed Web of Science ®Google Scholar
• Greenslade JH, Carlton EW, Van Hise C, et al. Diagnostic accuracy of a new high-sensitivity troponin i assay and five accelerated diagnostic pathways for ruling out acute myocardial infarction and acute coronary syndrome. Ann Emerg Med. 2018;71(4):439–451.e3. doi:10.1016/j.annemergmed.2017.10.030
   PubMed Web of Science ®Google Scholar
• Greenslade J, Cho E, Van Hise C, et al. Evaluating rapid rule-out of acute myocardial infarction using a high-sensitivity cardiac troponin I assay at presentation. Clin Chem. 2018;64(5):820–829. doi:10.1373/clinchem.2017.283887
   PubMed Web of Science ®Google Scholar
• Nestelberger T, Boeddinghaus J, Greenslade J, et al. Two-hour algorithm for rapid triage of suspected acute myocardial infarction using a high-sensitivity cardiac troponin I assay. Clin Chem. 2019;65(11):1437–1447. doi:10.1373/clinchem.2019.305193
   PubMed Web of Science ®Google Scholar
• Clerico A, Padoan A, Zaninotto M, et al. Clinical relevance of biological variation of cardiac troponins. Clin Chem Lab Med. 2020. doi:10.1515/cclm-2020-1433
   Web of Science ®Google Scholar
• Sigurdardottir FD, Lyngbakken MN, Holmen OL, et al. Relative prognostic value of cardiac troponin I and c-reactive protein in the general population (from the nord-trøndelag health [HUNT] study). Am J Cardiol. 2018;121:949–955. doi:10.1016/j.amjcard.2018.01.004
   PubMed Web of Science ®Google Scholar
• Pettit MA, Koyfman A, Foran M. Myocarditis. Pediatr Emerg Care. 2014;30(11):832–5;quiz 836–8. doi:10.1097/PEC.0000000000000272
   PubMed Web of Science ®Google Scholar
• Chaudary N, Geraci SA. Prognostic value of cardiac-specific troponins in chronic obstructive pulmonary disease exacerbations: a systematic review. J Miss State Med Assoc. 2014;55(2):40–44.
   PubMedGoogle Scholar
• Gaze DC. Clinical utility of cardiac troponin measurement in COVID-19 infection. Ann Clin Biochem. 2020;57(3):202–205. doi:10.1177/0004563220921888
   PubMed Web of Science ®Google Scholar